Morpho-molecular functional drug response analysis of patient-derived organoids of colorectal cancer

Xu Li; Arno Krause; Gabriel Giardina; Zewen Jiang; Marco Andreana; Veronika Huntošová; Angelika Unterhuber

doi:10.1117/12.3000978

12 March 2024 Morpho-molecular functional drug response analysis of patient-derived organoids of colorectal cancer

Xu Li, Arno Krause, Gabriel Giardina, Zewen Jiang, Marco Andreana, Veronika Huntošová, Angelika Unterhuber

Proceedings Volume 12836, Optical Biopsy XXII: Toward Real-Time Spectroscopic Imaging and Diagnosis; 128360D (2024) https://doi.org/10.1117/12.3000978
Event: SPIE BiOS, 2024, San Francisco, California, United States

Abstract

Nanoparticle-based drug delivery systems have shown potential for cancer treatment. Due to their size, nanoparticles penetrate into tumors, facilitate drug uptake, enable efficient drug delivery and ensure efficacy at the target site. They present good pharmacokinetics, precisely target tumor cells, reduce side effects and drug resistance. Recently, patient-derived organoids (PDOs) of colorectal cancer (CRC) patients proved to be a valuable tool to study the pathological, physiological, and genetic characteristics of CRC. In particular, they can be employed to test drugs in-vitro in a complex heterogeneous environment. We use UiO-66-NH2 nanoparticles as drug delivery carriers for 5-Fluorouracil (5-FU) to PDOs of CRC to study interactions between organoids and nanoparticles. Since PDOs preserve tumor heterogeneity to a significant extent, we investigate the structural, metabolic, and molecular changes in PDOs across different CRC and the impact of UiO-66-NH2 as carrier for 5-FU with our custom multimodal optical microscope offering complementary co-registered contrast from Optical Coherence Tomography (OCT), Multiphoton Microscopy (MPM), and Raman Microscopy (RM). We examine the interactions between nanoparticles and PDOs of CRC as well as their response to 5-FU. We assess the influence of the drug by extracting morphological features from OCT/MPM images, distinguish PDOs phenotypic differences through RM molecular analysis, identifying alterations in relevant biomarkers such as lipids, proteins, collagen, DNA, further analyze molecular metabolic differences and conduct sample classification. We demonstrate the significant potential of our multimodal imaging system in the analysis of PDOs and nano-medicine effects, enabling high-precision morpho-molecular metabolic analysis and classification.

Conference Presentation

(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.

Citation Download Citation

Xu Li, Arno Krause, Gabriel Giardina, Zewen Jiang, Marco Andreana, Veronika Huntošová, and Angelika Unterhuber "Morpho-molecular functional drug response analysis of patient-derived organoids of colorectal cancer", Proc. SPIE 12836, Optical Biopsy XXII: Toward Real-Time Spectroscopic Imaging and Diagnosis, 128360D (12 March 2024); https://doi.org/10.1117/12.3000978

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available